Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces First Canadian Cataract Procedures Using Zepto Capsulotomy System

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), is pleased to announce the first four cataract...
May 31, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Provides First Quarter 2018 Financial and Corporate Highlights

VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
May 16, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces Official Launch of Zepto Capsulotomy System in Canada to be June 1, 2018

VANCOUVER, British Columbia, May 16, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), is pleased to announce it will be formally launching...
May 03, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch

Key Highlights FDA has confirmed that an abbreviated 505(b)(2) regulatory pathway would be appropriate for the submission of AQS1303, Aequus’ long-acting anti-nausea patch for nausea and vomiting...
April 27, 2018 09:30 ET | Source: Aequus Pharmaceuticals

Aequus Provides Fourth Quarter and Fiscal 2017 Financial Highlights, Third Consecutive Quarter of Revenue Growth

VANCOUVER, British Columbia, April 27, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
April 26, 2018 12:00 ET | Source: Aequus Pharmaceuticals

Aequus to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2018

VANCOUVER, British Columbia, April 26, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
April 17, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus and Camargo Complete Pre-Investigational New Drug Submission with FDA for Transdermal Anti-Nausea Program

VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
April 12, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Adds Zepto Capsulotomy System, A Revenue Generating Product, to Commercial Ophthalmology Portfolio

VANCOUVER, B.C., April 12, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), is pleased to announce it has entered into a commercial...
March 19, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Expands Market in Quebec for Tacrolimus IR

VANCOUVER, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), announced today that it has been awarded a...
March 07, 2018 08:45 ET | Source: Aequus Pharmaceuticals

FDA Confirms Date to Providing Regulatory Guidance for Aequus’ Anti-Nausea Patch

VANCOUVER, British Columbia, March 07, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...